Application of remimazolam anesthesia in elderly patients undergoing radical resection for colorectal cancer: a cohort study on gastrointestinal recovery and complication rates - Takeaways - MDSpire

Application of remimazolam anesthesia in elderly patients undergoing radical resection for colorectal cancer: a cohort study on gastrointestinal recovery and complication rates

  • By

  • Yanming Xue

  • Jie Zhang

  • July 8, 2026

  • 0 min

Share

  • 1

    This study assessed remimazolam versus propofol anesthesia in elderly patients undergoing radical colorectal cancer surgery.

  • 2

    243 patients were analyzed, with 115 receiving remimazolam and 128 receiving propofol after propensity score matching.

  • 3

    Remimazolam was associated with higher motilin and gastrin levels and shorter gastrointestinal recovery times compared to propofol.

  • 4

    Postoperative complications such as nausea/vomiting and delirium were lower in the remimazolam group than in the propofol group.

  • 5

    QoR-15 scores were significantly higher in the remimazolam group, indicating better recovery quality compared to the propofol group.

Original Source(s)

Application of remimazolam anesthesia in elderly patients undergoing radical resection for colorectal cancer: a cohort study on gastrointestinal recovery and complication rates

  • by Yanming Xue, Jie Zhang

  • July 8, 2026

Related Content

Correction: Olaparib-mediated enhancement of 5-fluorouracil cytotoxicity in mismatch repair deficient colorectal cancer cells

Evidence-based strategies to improve implementation of tumor isolation techniques in colorectal cancer surgery

HDAC1-mediated CDK1 decrotonylation inhibits colorectal cancer proliferation by regulating cell cycle and apoptosis